Occipital neuralgia is characterized by irritation or injury to the occipital nerves, resulting in sharp, shooting pain at the base of the skull
Patron et al
No cell-related safety issues were encountered in this trial, although the patients receiving 18*10 6 MSCs showed a higher incidence of adverse effects ( Lastly, several human growth factor-based phase I/II clinical trials were started to evaluate the safety, tolerability, and preliminary effectiveness of intradiscal delivery of growth and differentiation factor-5 (GDF-5) as compared with placebo (sterile water/vehicle control) in human patients with early lumbar disc degeneration in the United States, Australia, and the Republic of Korea
You have a confirmed, symptomatic deficiency: When a deficiency is significant and affecting daily life, a provider may recommend injections as part of the treatment plan
Significant Wrinkle Reduction: Research measured a 55.8% reduction in wrinkle volume and 32.8% in depth over 12 weeks, surpassing Matrixyl 3000 by 31.6%